Home
resources
pipeline
Contact Us
Published
August 14, 2020

SMSbiotech Interviews with Dr. Roger Schechter EPISODE 2: Accessibility of SMS Cells

Interview
SMSbiotech Interviews with Dr. Roger Schechter EPISODE 2: Accessibility of SMS Cells

Today Dr. Abdulkader Rahmo, CEO of SMSbiotech, sat down again with Roger Schechter, M.D, to discuss the accessibility of SMS cells. If you have any comments, please send us a message!

-

Conclusion

August 14, 2020
Copy link
This is some text inside of a div block.
Back to Lobby
SMSbiotech Receives New European Patent!
Next Article
American Thoracic Society 2024 Respiratory Innovation Summit
Next Article
VIP Speaker at 7th Alcor Drug Discovery Platform
Next Article
12th Annual Drug Discovery Strategic Summit
Next Article
5th Annual Age-Related Disease Therapeutics Summit
Next Article
Biocom Global Life Science Partnering & Investor Conference
Next Article
Unveiling Hope: A Potential Breakthrough Treatment for COPD from SMSbiotech
Next Article
6th Annual CGTI Leaders Summit 2023
Next Article
SMSbiotech Unveils New Patented Stem-Cell Technology Designed to Treat COPD
Next Article
Cell Symposia: Advances in Therapeutic Applications of Stem Cells
Next Article
10th International Conference on COPD and Lung Health
Next Article
Patent Application Accepted
Next Article
6th Annual IPF Summit 2022
Next Article
4th Annual Longevity Therapeutics Summit
Next Article
Voice of America - Innovations
Next Article
SMSbiotech Receives New Patent!!!
Next Article
ISSCR 2022 Poster Presentation
Next Article
Scientific Poster from ATS: Respiratory Innovation Summit 2022
Next Article
ATS: Respiratory Innovation Summit 2022
Next Article
Medicinal Chemistry Strategy Meeting - 2022
Next Article
Health 2.0 - Presentation
Next Article
Health 2.0 Conference 2022
Next Article
Advanced Therapies Week: Phacilitate 2022
Next Article
SMSbiotech Welcome Beth Thompson-Webb to Board of Directors
Next Article
5th Meridian Clinical Trials Event
Next Article
SMSbiotech Successfully Completes First Test of a Series of Animal Studies for COPD Treatment
Next Article
SMSbiotech Announces Collaboration with Acculab Life Sciences
Next Article
SMSbiotech Selected for the ACSFall2021 Sci-Mix Event
Next Article
American Chemical Society Fall 2021 Presentation
Next Article
Nobel Laureate, Professor Luc Montagnier, Joins the SMSbiotech Advisory Board
Next Article
Small Mobile Stem Cells: Potential for Multi-Targeted Therapy of Emphysema in COPD - AASCP
Next Article
Prof. Peter D. Wagner, MD joins SMSbiotech on their Advisory Board
Next Article
SMSbiotech Completes Second Clinical Test for Chronic Non-Healing Wound Product
Next Article
In Vitro Gene Expression Study Demonstrates Small Mobile Stem Cells Stimulate Progenitor Lung Cells
Next Article
SMSbiotech Completes Clinical Test for Chronic Non-Healing Wound Product
Next Article
SMSbiotech Engages Exemplar Capital for Strategic Investment Banking Services
Next Article
MSC's In the Treatment of COVID-19
Next Article
Interviews with Dr. Roger Schechter: Episode 5: COVID-19 Part 2 (Effects and Solutions)
Next Article
Interviews with Dr. Roger Schechter EPISODE 4: COVID-19 Part 1
Next Article
Meet Abdulkader Rahmo, PhD.
Next Article
SMSbiotech Interviews with Dr. Roger Schechter EPISODE 3: Angiogenesis and SMS Cells
Next Article
SMSbiotech Interviews with Dr. Roger Schechter EPISODE 2: Accessibility of SMS Cells
Next Article
SMSbiotech Interviews with Dr. Roger Schechter EPISODE 1: Aging and Cell Therapy
Next Article
Ageing Hallmarks Exhibit Organ-Specific Temporal Signatures
Next Article
BioNeex Interview with SMSbiotech
Next Article
ACS National Meeting & Expo
Next Article
SMSbiotech Files Proposal with BARDA for a Covid-19 Treatment
Next Article
SAWC Spring | WHS
Next Article
Advanced Therapies Congress & Expo 2020
Next Article
Joe Kiani Becomes A Major Shareholder At SMSbiotech, Inc.
Next Article
SMSbiotech Introduces a New Product Website!
Next Article
ANGIOstream™ In Vitro Assay Fast Track Option – Inductive Niche Module (INM)
Next Article
Biotechnology Vendor Showcase™ – Southern California
Next Article
Biotechnology Vendor Showcase™ Events – Southern California
Next Article
Cell Symposia - Engineering Organoids and Organs
Next Article
ICancer 2019: 3rd International Cancer Conference And Expo
Next Article
20th Annual SoCalBio Conference
Next Article
SMSbiotech Obtains Patent
Next Article
Biocom Regenerative Medicine Fly-In – Washington DC
Next Article
New Facility Opens In San Marcos, CA
Next Article
Connector Series: SMSbiotech By Hai Truong (UCI)​
Next Article
SMSbiotech Celebrates Proof of Concept Victory!
Next Article
5th World Congress on Cell & Stem Cell Research, 2015
Next Article
2nd International Conference and Exhibition on Cell and Gene Therapy, 2013
Next Article
A New Era of Healing: Our Latest Patent is Here!
Next Article
SMSbiotech Welcomes New Board of Advisor Member Dr. Jason P. Kirkness
Next Article

Recent blog posts

A New Era of Healing: Our Latest Patent is Here!
Company News

A New Era of Healing: Our Latest Patent is Here!

December 13, 2024
SMSbiotech Welcomes New Board of Advisor Member Dr. Jason P. Kirkness
Company News

SMSbiotech Welcomes New Board of Advisor Member Dr. Jason P. Kirkness

December 13, 2024
SMSbiotech Receives New European Patent!
Company News

SMSbiotech Receives New European Patent!

Title: COMPOSITIONS AND METHODS FOR USING SMALL MOBILE STEM CELLS Issued: September 4, 2024

September 4, 2024